id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-P-2008-0007,FDA,FDA-2020-P-2008,Response Letter from FDA CDRH to Andy Zeltwanger,Other,Dismissal,2023-09-21T04:00:00Z,2023,9,2023-09-21T04:00:00Z,,2023-09-21T15:39:46Z,,0,0,0900006485fde893